Index of reports
> Life Threatening Events (162)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisone life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 162 Next >>
Possible Prednisone side effects in male
Reported by a physician from Brazil on 2012-08-21
Patient: male, weighing 64.4 kg (141.7 pounds)
Reactions: Diarrhoea
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Abiraterone Acetate
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2011-11-10
End date: 2012-06-23
Abiraterone Acetate
Administration route: Oral
Prednisone
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2011-11-10
End date: 2012-06-23
Other drugs received by patient: Goserelin
Possible Prednisone side effects in male
Reported by a physician from Brazil on 2012-08-21
Patient: male, weighing 53.1 kg (116.8 pounds)
Reactions: Pneumonia, Deep Vein Thrombosis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Abiraterone Acetate
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2011-12-01
End date: 2012-02-14
Abiraterone Acetate
Administration route: Oral
Prednisone
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2011-12-01
End date: 2012-02-14
Other drugs received by patient: Hydromorphone HCL
Possible Prednisone side effects in male
Reported by a physician from Romania on 2012-08-21
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Cardio-Respiratory Arrest, Anaemia, Dehydration
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Abiraterone Acetate
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2011-12-16
End date: 2012-06-16
Abiraterone Acetate
Administration route: Oral
Prednisone
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2011-12-16
End date: 2012-06-16
Possible Prednisone side effects in 64 year old male
Reported by a physician from Poland on 2012-08-21
Patient: 64 year old male
Reactions: Disseminated Intravascular Coagulation
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cabazitaxel
Start date: 2012-07-04
End date: 2012-07-04
Cabazitaxel
Indication: Prostate Cancer Metastatic
Start date: 2012-06-14
End date: 2012-06-14
Prednisone
Indication: Prostate Cancer Metastatic
Start date: 2012-06-14
Possible Prednisone side effects in 60 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-09
Patient: 60 year old female
Reactions: Myelofibrosis, Acute Myeloid Leukaemia, Myelodysplastic Syndrome, Idiopathic Thrombocytopenic Purpura
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Alkeran
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Bicnu
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Cyclophosphamide
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Dexamethasone
Dosage: 4 years, intravenous (not otherwise specified)
Indication: Multiple Myeloma
Doxorubicin Hydrochloride
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Prednisone
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Velcade
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Start date: 2008-05-05
Velcade
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Start date: 2008-05-19
Velcade
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Start date: 2008-04-08
Vepesid
Dosage: intravenous (not otherwise sepcified)
Indication: Multiple Myeloma
Vincristine Sulfate
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Other drugs received by patient: Neupogen; Corticosteroids
Possible Prednisone side effects in 58 year old male
Reported by a physician from United States on 2012-08-08
Patient: 58 year old male, weighing 121.7 kg (267.7 pounds)
Reactions: Encephalopathy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Docetaxel
Indication: Prostate Cancer Metastatic
Start date: 2011-09-30
End date: 2011-09-30
Docetaxel
Start date: 2012-02-23
End date: 2012-02-23
Prednisone
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2011-09-30
End date: 2012-03-05
Other drugs received by patient: Glipizide; Lisinopril; Herbal Preparation; Dorzolamide; Rosuvastatin; Sertraline Hydrochloride; Aspirin; Bisoprolol Fumarate; Goserelin; Pioglitazone; Folic Acid; ST Mary's Thistle; Acyclovir; Ezetimibe; Metformin Hydrochloride; Fish OIL; Garlic; Biotin; Carboxymethylcellulose Sodium; Doxycycline Hyclate; Hydrocortisone; Calcium; Cholecalciferol
Possible Prednisone side effects in 67 year old male
Reported by a consumer/non-health professional from United States on 2012-08-07
Patient: 67 year old male
Reactions: Nasopharyngitis, Cataract, Bronchitis, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Nexium
Administration route: Oral
Prednisone
Toprol-XL
Administration route: Oral
Possible Prednisone side effects in
Reported by a individual with unspecified qualification from United States on 2012-08-07
Patient:
Reactions: Lung Infection, Febrile Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: over 30-60 minutes on day 3
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-08
End date: 2012-02-08
Cyclophosphamide
Dosage: over 30-60 minutes on day 3
Start date: 2012-07-12
End date: 2012-07-12
Cyclophosphamide
Dosage: over 30-60 minutes on day 3
Start date: 2012-03-01
End date: 2012-03-01
Doxorubicin Hydrochloride
Dosage: 50 mg/m2, on day 3
Start date: 2012-07-12
End date: 2012-07-12
Doxorubicin Hydrochloride
Dosage: 50 mg/m2, on day 3
Start date: 2012-03-01
End date: 2012-03-01
Doxorubicin Hydrochloride
Dosage: 50 mg/m2, on day 3
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-08
End date: 2012-02-08
Prednisone
Dosage: 100 mg, qd on days 3-7
Administration route: Oral
Start date: 2012-03-01
End date: 2012-03-05
Prednisone
Dosage: 100 mg, qd on days 3-7
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-08
End date: 2012-02-12
Prednisone
Dosage: 100 mg, qd on days 3-7
Administration route: Oral
Start date: 2012-07-12
End date: 2012-07-12
Rituximab
Dosage: 375 mg/m2, on day 3
Start date: 2012-03-01
End date: 2012-03-01
Rituximab
Dosage: 375 mg/m2, on day 3
Start date: 2012-07-12
End date: 2012-07-12
Rituximab
Dosage: 375 mg/m2, on day 3
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-08
End date: 2012-02-08
Vincristine Sulfate
Dosage: 1.4 mg/m2, on day 3
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-08
End date: 2012-02-08
Vincristine Sulfate
Dosage: 1.4 mg/m2, on day 3
Start date: 2012-07-12
End date: 2012-07-12
Vincristine Sulfate
Dosage: 1.4 mg/m2, on day 3
Start date: 2012-03-01
End date: 2012-03-01
Vorinostat
Dosage: on day 1-9
Administration route: Oral
Start date: 2012-02-28
End date: 2012-03-07
Vorinostat
Dosage: on day 1-9
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-02-14
Vorinostat
Dosage: on day 1-5
Administration route: Oral
Start date: 2012-07-10
End date: 2012-07-14
Possible Prednisone side effects in male
Reported by a physician from France on 2012-08-07
Patient: male, weighing 67.0 kg (147.4 pounds)
Reactions: Myocardial Infarction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Lymphoma
Start date: 2012-07-05
End date: 2012-07-05
Cyclophosphamide
Indication: Lymphoma
Start date: 2012-07-05
End date: 2012-07-05
Istodax
Istodax
Dosage: 21.6 milligram
Indication: Lymphoma
Start date: 2012-07-05
End date: 2012-07-05
Oncovin
Indication: Lymphoma
Start date: 2012-07-05
End date: 2012-07-05
Prednisone
Indication: Lymphoma
Start date: 2012-07-05
End date: 2012-07-05
Possible Prednisone side effects in male
Reported by a physician from United States on 2012-08-06
Patient: male, weighing 125.0 kg (275.0 pounds)
Reactions: Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Abiraterone Acetate
Administration route: Oral
Abiraterone Acetate
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2011-12-22
End date: 2012-07-05
Prednisone
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2011-12-22
End date: 2012-07-04
Other drugs received by patient: Aspirin; Nexium; Degarelix; Acetaminophen; Docusate; Boniva; Nasonex; Pepcid; Hydrocodone Bitartrate; Potassium Chloride; Metamucil-2; Vitamin D; Carafate; Nasonex; Bumetanide; Potassium Chloride; Pepcid; Carafate; Toviaz; Potassium Chloride; Milk OF Magnesia TAB; Potassium Chloride; Calcium with Vitamin D; Miralax
Possible Prednisone side effects in 49 year old female
Reported by a pharmacist from United States on 2012-08-06
Patient: 49 year old female, weighing 35.4 kg (77.9 pounds)
Reactions: Medication Error, Endocarditis, Hepatic Cirrhosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisone
Dosage: tapering dosage daily po
Administration route: Oral
Indication: Hepatic Failure
Start date: 2012-06-20
End date: 2012-07-07
Prednisone
Dosage: tapering dosage daily po
Administration route: Oral
Indication: Hepatic Failure
Start date: 2012-06-25
End date: 2012-07-18
Other drugs received by patient: Furosemide; Spironolactone; Levothyroxine Sodium
Possible Prednisone side effects in 74 year old male
Reported by a consumer/non-health professional from United States on 2012-08-03
Patient: 74 year old male
Reactions: Blood Bilirubin Increased, Pneumonia, Atrial Fibrillation, Hepatic Enzyme Increased, Death, Enterococcal Sepsis, Fluid Retention, Cardiac Failure Congestive
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Daunorubicin HCL
Dosage: on days 1,8,15,22
Indication: Acute Lymphocytic Leukaemia
Elspar
Methotrexate
Dosage: day15
Indication: Acute Lymphocytic Leukaemia
Prednisone
Indication: Acute Lymphocytic Leukaemia
Sprycel
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-22
Vincristine
Dosage: on days 1,8,15,22
Indication: Acute Lymphocytic Leukaemia
Possible Prednisone side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02
Patient: 56 year old female
Reactions: Abdominal Pain, Confusional State, Tachycardia, Mental Status Changes, Clostridium Difficile Colitis, Pneumocystis Jiroveci Pneumonia, Abdominal Distension, Respiratory Muscle Weakness, Hypoxia, Clostridial Infection, Hypotension, Urinary Tract Infection Enterococcal, Respiratory Failure, Diarrhoea, Pseudomembranous Colitis, Enteritis Infectious, Septic Shock
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Levofloxacin
Dosage: 250 mg
Indication: Antibiotic Prophylaxis
Prednisone
Dosage: 10 mg
Indication: Chronic Graft Versus Host Disease
Sulfamethoxazole and Trimethoprim
Dosage: double strength
Administration route: Oral
Indication: Antibiotic Prophylaxis
Sulfamethoxazole and Trimethoprim
Indication: Pneumocystis Jiroveci Pneumonia
Other drugs received by patient: Pentamidine; Fluconazole; Acyclovir
Possible Prednisone side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01
Patient: female
Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Alkeran
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Bicnu
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Cyclophosphamide
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Dexamethasone
Start date: 2008-04-08
Dexamethasone
Start date: 2008-06-01
End date: 2008-01-01
Dexamethasone
Indication: Multiple Myeloma
Start date: 2008-05-05
Dexamethasone
Start date: 2008-05-19
Doxorubicin Hydrochloride
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Prednisone
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Velcade
Indication: Multiple Myeloma
Start date: 2008-04-08
End date: 2008-09-01
Vepesid
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Vincristine
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Possible Prednisone side effects in
Reported by a consumer/non-health professional from United States on 2012-08-01
Patient:
Reactions: Rhabdomyolysis, Dehydration
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Abiraterone Acetate
Administration route: Oral
Prednisone
Administration route: Oral
Zocor
Administration route: Oral
Other drugs received by patient: Fluticasone Furoate; Systane Ultra; Restasis; Aspirin; Metoprolol Tartrate; Zaleplon
Possible Prednisone side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01
Patient: female
Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Alkeran
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Bicnu
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Cyclophosphamide
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Dexamethasone
Indication: Multiple Myeloma
Start date: 2004-01-01
End date: 2008-01-01
Dexamethasone
Start date: 2008-04-08
End date: 2008-09-01
Doxorubicin Hydrochloride
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Prednisone
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Velcade
Indication: Multiple Myeloma
Start date: 2008-04-08
End date: 2008-06-01
Vepesid
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Vincristine
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Possible Prednisone side effects in male
Reported by a physician from Canada on 2012-07-30
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: Platelet Count Decreased, Neutropenia, Altered State of Consciousness
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Abiraterone Acetate
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2012-04-16
End date: 2012-04-23
Abiraterone Acetate
Administration route: Oral
Start date: 2012-04-27
End date: 2012-04-29
Prednisone
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2012-04-02
Other drugs received by patient: Phosphate
Possible Prednisone side effects in
Reported by a physician from Korea, Republic of on 2012-07-30
Patient:
Reactions: Blood Bilirubin Increased, Hepatic Function Abnormal, Transaminases Increased, Disease Progression
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 750 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Doxil
Dosage: 50 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Prednisone
Dosage: 100 mg, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-26
Velcade
Dosage: 1.60 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Vincristine
Dosage: 1.4 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Possible Prednisone side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Acute Myocardial Infarction, Clostridial Infection, Immunosuppression, Renal Failure Acute, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Encephalopathy, Atrial Fibrillation, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Velcade
End date: 2012-04-10
Other drugs received by patient: Lotrel; Pravastatin; Vitamin D; Coreg; Doxepin; Tricore; Betaseron; Acyclovir; Allopurinol; Aspirin; Heocyte; Metformin Hydrochloride; Warfarin Sodium; Doxil
Possible Prednisone side effects in female
Reported by a consumer/non-health professional from United Kingdom on 2012-07-27
Patient: female, weighing 43.0 kg (94.6 pounds)
Reactions: Meningitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-03-08
End date: 2012-06-13
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-03-08
End date: 2012-06-13
Prednisone
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-03-07
End date: 2012-06-13
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-03-08
End date: 2012-06-13
Possible Prednisone side effects in female
Reported by a physician from United Kingdom on 2012-07-27
Patient: female, weighing 53.0 kg (116.6 pounds)
Reactions: Anaemia, Neutropenia, Hypokalaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Furosemide
Prednisone
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Possible Prednisone side effects in male
Reported by a physician from Mexico on 2012-07-27
Patient: male, weighing 2.0 kg (4.4 pounds)
Reactions: Klippel-Feil Syndrome, Respiratory Distress
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Foetal Exposure During Pregnancy
Prednisone
Indication: Foetal Exposure During Pregnancy
Possible Prednisone side effects in
Reported by a physician from Korea, Republic of on 2012-07-24
Patient:
Reactions: Blood Bilirubin Increased, Hepatic Function Abnormal, Transaminases Increased, Disease Progression
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 750 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Doxil
Dosage: 50 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Prednisone
Dosage: 100 mg, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-26
Velcade
Dosage: 1.60 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Vincristine
Dosage: 1.4 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Possible Prednisone side effects in female
Reported by a physician from Switzerland on 2012-07-19
Patient: female, weighing 50.0 kg (110.0 pounds)
Reactions: Alveolitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Actemra
Indication: Temporal Arteritis
Start date: 2012-06-01
End date: 2012-06-01
Methotrexate
Administration route: Oral
Methotrexate
Indication: Temporal Arteritis
Start date: 2012-01-03
End date: 2012-05-29
Methotrexate
Prednisone
Prednisone
Administration route: Oral
Indication: Temporal Arteritis
Start date: 2011-09-01
Prednisone
Possible Prednisone side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Cardiac Failure Congestive, Immunosuppression, Renal Failure Acute, Pneumonia, Dyspnoea, Malnutrition, Atrial Fibrillation, Febrile Neutropenia, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
End date: 2012-04-10
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Other drugs received by patient: Doxil; Coreg; Pravastatin; Heocyte; Betaseron; Lotrel; Aspirin; Vitamin D; Warfarin Sodium; Allopurinol; Doxepin; Acyclovir; Metformin Hydrochloride; Tricore
Possible Prednisone side effects in
Reported by a physician from Korea, Republic of on 2012-07-18
Patient:
Reactions: Blood Bilirubin Increased, Hepatic Function Abnormal, Transaminases Increased, Disease Progression
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 750.00 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Doxorubicin HCL
Dosage: 50.00 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Prednisone
Dosage: 100.00 mg, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-26
Velcade
Dosage: 1.60 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Vincristine
Dosage: 1.40 mg/m2, unk
Indication: T-Cell Lymphoma
Start date: 2008-01-24
End date: 2008-02-22
Possible Prednisone side effects in
Reported by a physician from United Kingdom on 2012-07-18
Patient:
Reactions: Neutropenic Sepsis, Respiratory Arrest
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1300 mg, unk
Start date: 2010-11-05
Cyclophosphamide
Dosage: 1300 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2010-08-24
End date: 2010-11-05
Doxorubicin HCL
Dosage: 90 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2010-08-24
Doxorubicin HCL
Dosage: 83 unk, unk
Start date: 2010-11-05
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Mantle Cell Lymphoma
Start date: 2010-08-24
End date: 2010-11-05
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2010-11-05
Velcade
Dosage: 2.8 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2010-08-24
Velcade
Dosage: 1.3 unk, unk
Start date: 2010-11-05
End date: 2010-11-12
Vincristine
Dosage: 2 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2010-08-24
Other drugs received by patient: Metoclopramide; Simvastatin; Ramipril; Acyclovir; Piperacillin and Tazobactam; Fluoxetine HCL; E45; Aspirin; Gaviscon; Bisoprolol Fumarate; Omeprazole
Possible Prednisone side effects in 56 year old female
Reported by a physician from United States on 2012-07-18
Patient: 56 year old female, weighing 81.0 kg (178.2 pounds)
Reactions: Fluid Overload, Gastroenteritis Viral
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Humira
Start date: 2012-02-29
Humira
Indication: Uveitis
Start date: 2011-09-14
End date: 2012-02-08
Prednisone
Dosage: 60 mg
Administration route: Oral
Indication: Uveitis
Start date: 2011-09-14
End date: 2011-09-27
Prednisone
Dosage: 30 mg
Administration route: Oral
Start date: 2011-10-12
End date: 2011-10-18
Prednisone
Dosage: 12.5 mg
Administration route: Oral
Start date: 2011-11-02
End date: 2011-11-08
Prednisone
Dosage: 5 mg
Administration route: Oral
Start date: 2011-11-24
End date: 2011-11-30
Prednisone
Dosage: 7.5 mg
Administration route: Oral
Start date: 2011-11-17
End date: 2011-11-23
Prednisone
Dosage: 10 mg
Administration route: Oral
Start date: 2011-11-09
End date: 2011-11-16
Prednisone
Dosage: 15 nr
Administration route: Oral
Start date: 2011-10-26
End date: 2011-11-01
Prednisone
Dosage: 3 mg
Administration route: Oral
Start date: 2011-12-08
End date: 2011-12-14
Prednisone
Dosage: 1 mg
Administration route: Oral
Start date: 2011-12-22
End date: 2011-12-28
Prednisone
Dosage: 50 mg
Administration route: Oral
Start date: 2011-09-28
End date: 2011-10-04
Prednisone
Dosage: 40 mg
Administration route: Oral
Start date: 2011-10-05
End date: 2011-10-11
Prednisone
Dosage: 20 mg
Administration route: Oral
Start date: 2011-10-19
End date: 2011-10-25
Prednisone
Dosage: 2 mg
Administration route: Oral
Start date: 2011-12-15
End date: 2011-12-21
Prednisone
Dosage: 4 mg
Administration route: Oral
Start date: 2011-12-01
End date: 2011-12-07
Other drugs received by patient: Lisinopril; Lorazepam; Ketorolac Tromethamine; Mycophenolate Mofetil; Promethazine; Rosuvastatin; Folic Acid; Tramadol HCL; Metoprolol Succinate; Diclofenac Sodium; Furosemide; Sertraline Hydrochloride; Amlodipine Maleate; Mycophenolate Mofetil; Gabapentin; Vicodin; Cyclobenzaprine HCL; Loratadine; Furosemide; Mycophenolate Mofetil; Calcium with D; Pantoprazole Sodium Sesquihydrate; Amlodipine Maleate; Bupropion Hydrochloride; Suprax; Estradiol
Possible Prednisone side effects in 70 year old male
Reported by a physician from Canada on 2012-07-17
Patient: 70 year old male
Reactions: Small Intestinal Obstruction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cabazitaxel
Indication: Prostate Cancer Metastatic
Start date: 2012-06-05
End date: 2012-06-05
Cabazitaxel
Start date: 2012-06-26
End date: 2012-06-26
Prednisone
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2012-06-05
End date: 2012-06-05
Other drugs received by patient: Ezetimibe; Simvastatin; Bisoprolol Fumarate; Aspirin
Possible Prednisone side effects in male
Reported by a physician from Italy on 2012-07-17
Patient: male, weighing 53.0 kg (116.6 pounds)
Reactions: Subdural Haemorrhage
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Abiraterone Acetate
Administration route: Oral
Abiraterone Acetate
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2012-06-07
End date: 2012-06-17
Prednisone
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2012-06-07
End date: 2012-06-17
Other drugs received by patient: Leuprolide Acetate
Page 1 Next >>
|